TTX-001 / Tessara Therap - LARVOL DELTA

REDUCTION IN MARKERS OF INFLAMMATION AND FIBROSIS IN HUMAN PENILE AND URETHRAL TISSUES USING A NOVEL ANTI-FIBROTIC ENDOSTATIN PEPTIDE DERIVED FROM COLLAGEN (AUA 2026) - "A single dose of TTX-001 significantly reduced inflammation and fibrosis-related gene expression in pathologic genitourinary tissues within 72 hours ex vivo. These findings suggest that TTX-001 exerts potent anti-inflammatory molecular and anti-fibrotic changes and may represent a promising non-surgical therapeutic interventions for chronic fibrotic conditions of the penis and urethra."

Fibrosis • Immunology • Inflammation • Urology • FN1 • IL6 • MMP1 • MMP3 • TGFB2

Tessara Therapeutics announces new collaboration with Florey Institute (Mirage News) - "Tessara Therapeutics has announced a collaboration with the Florey Institute of Neuroscience and Mental Health under which they will develop tissue therapies for the treatment of neurological diseases....Tessara said the initial focus will be on the development of tissue therapy TTX‑001 for Parkinson’s disease (PD)."

Licensing / partnership • CNS Disorders • Parkinson's Disease